Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
New England Journal of Medicine2016Vol. 375(23), pp. 2223–2235
Citations Over TimeTop 1% of 2016 papers
Gregg W. Stone, Joseph F. Sabik, Patrick W. Serruys, Charles A. Simonton, Philippe Généreux, John D. Puskas, David E. Kandzari, Marie-Claude Morice, Nicholas Lembo, W. Morris Brown, David P. Taggart, Adrian Banning, Béla Merkely, Ferenc Horkay, Piet W. Boonstra, Ad J. van Boven, Imre Ungi, Gábor Bogáts, Samer Mansour, Nicolas Noiseux, Manel Sabaté, José Luís Pomar, M. Hickey, Anthony Gershlick, Paweł Buszman, Andrzej Bochenek, Erick Schampaert, Pierre Pagé, Ovidiu Dressler, Ioanna Kosmidou, Roxana Mehran, Stuart Pocock, A. Pieter Kappetein
Abstract
In patients with left main coronary artery disease and low or intermediate SYNTAX scores by site assessment, PCI with everolimus-eluting stents was noninferior to CABG with respect to the rate of the composite end point of death, stroke, or myocardial infarction at 3 years. (Funded by Abbott Vascular; EXCEL ClinicalTrials.gov number, NCT01205776 .).
Related Papers
- → Adoption of Radial Access and Comparison of Outcomes to Femoral Access in Percutaneous Coronary Intervention(2013)463 cited
- → Recent advances in percutaneous coronary intervention(2020)154 cited
- → Impact of Gender on Elective and Non-Elective Percutaneous Coronary Intervention(2007)
- → Abstract 161: National Trends in Use of Radial Access for Percutaneous Coronary Intervention in China: 2001-2011(2015)